Xiao‐Dong Zhu

机构：Fudan University, Zhongshan Hospital · ORCID：0000-0001-9864-6763

发表论文 149 篇 · 总被引 7139 次 · h-index 45

代表论文

• China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition) (2025 · Liver Cancer · 被引 42)
• ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis (2024 · Cancer Research · 被引 33)
• MOF-engineered Cu2O nanozymes with boosted peroxidase-like activity for colorimetric-fluorescent dual-mode detection of deoxynivalenol (2025 · Microchimica Acta · 被引 10)
• Mechanisms of rifaximin inhibition of hepatic fibrosis in mice with metabolic dysfunction associated steatohepatitis through the TLR4/NFκB pathway (2025 · Scientific Reports · 被引 8)
• 1469MO Liver resection versus continued atezolizumab plus bevacizumab (atezo/bev) in locally advanced hepatocellular carcinoma (HCC) after atezo/bev treatment (TALENTop): A multicenter, open-label, randomized phase III trial (2025 · Annals of Oncology · 被引 7)
• Self-supported hierarchically aligned CoP-Co2P-Ni2P/Cu nanoarray for highly efficient electrocatalytic hydrogen evolution reaction at high current density (2025 · Chemical Engineering Science · 被引 7)